Interim Results and Investor Presentation

AI SummaryClose X

EMV Capital PLC announced its interim results for the six months ended 30 June 2025. Group revenue slightly decreased to £1.1 million from £1.2 million in H1 2024, with £1.0 million coming from EMV Capital core revenue. Group losses decreased to £1.5 million, compared to £1.8 million in H1 2024. Total assets increased to £19.7 million from £19.5 million at FY 2024, while net assets decreased slightly to £13.6 million. Adjusted net assets decreased to £29.3 million. Cash on the balance sheet was £0.5 million, with £1.0 million in readily realisable quoted securities. Total Assets Under Management stood at £104.7 million. EMV Capital Partners syndicated £5.0 million in new investments. Post balance sheet, Martlet Capital received exit proceeds of c.£320k and EMV Capital acquired IP and clinical assets from Destiny Pharma for up to £2.475 million.

Disclaimer*

Companies

Emv Capital (EMVC)
UK 100

Latest directors dealings